IMPACTS OF IMMUNOSUPPRESSION ON THE GRAVITY OF COVID-19 IN INDIVIDUALS CO-INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS (HIV)

Objective: To identify the levels of severity COVID-19 in individuals co-infected with Human Immunodeficiency Virus (HIV). Methods: Expanded summary literature review type. The searches were carried out main databases BVS and CAPES. above authors declare that they do not have conflict interest this study. Results: Most being treated antiretrovirals (83-100%) and, therefore, most had a TCD4 lymphocyte count 200 cells/µL viral load ranging between 67-100%. Comorbidities ranged from 33-70% deaths 0-14%. picture was mostly mild, at minimum proportion 63%, significantly differing population general, which on average remains mild symptomatic picture, around 80%. Therefore, percentage more severe disease lower than expected due to immune deficiency HIV positive people. Conclusion: It is rash make generalizations about topic or safely close hypothesis immunosuppression HIV, SARS-CoV-2 has an increased risk acquire form COVID-19. This because studies found did sample participants significant enough.